ITGAM and chronic myelogenous leukemia, BCR-ABL1 positive: Myeloid cells (CD11b+) in CML patients and control subjects were analyzed for the co-inhibitory molecule PD-L1 expression by flow cytometry (for gating, see Figure S3).